The size of the Lung Cancer Surgery Market in the Asia Pacific has been estimated at USD 6.06 billion in 2020 and is projected to reach USD 9.29 billion by 2025, growing at a CAGR of 9% from 2020 to 2025.
Lung Cancer is a kind of cancer that starts in Lung tissue or its surrounding parts. There are various types of treatments available to treat cancer like Chemotherapy, Radiotherapy, Laser Therapy, and Surgery. Surgery involves the removal of an infected parts from the lungs. In some cases, surgery will be used with other treatment methods to cure cancer. Surgery is only used if cancer cells don’t spread very near to the heart.
Rising pollution levels, an increasing number of cigarette smokers, rising incidence and prevalence of Lung Cancer and rising geriatric population are some of the major factors driving the market.
However, the high cost of Lung Cancer surgery is restraining the growth of the market.
This research report on the Asia Pacific Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories:
By Procedure:
By Device:
By Country:
On the basis of procedure, the Minimally Invasive surgeries are expected to grow at the highest CAGR owing to the rising awareness among people for early detection of lung cancer and the advantages of Minimally Invasive Surgeries over conventional surgeries.
On the basis of the device, the Surgical Instruments segment is expected to dominate the market owing to the shorter lifespan of devices and wider adoption of these devices.
Geographically, Europe has the second-largest market after North America owing to its Advanced Healthcare facilities and higher awareness among people and greater economic stability.
Notable companies dominating the Asia Pacific Lung Cancer Surgery Market include Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Procedure
5.1.1 Introduction
5.1.2 Thoracotomy
5.1.2.1 Lobectomy
5.1.2.2 Pneumonectomy
5.1.2.3 Sleeve Resection
5.1.2.4 Segmentectomy
5.1.3 Minimally Invasive
5.1.4 Y-o-Y Growth Analysis, By Procedure
5.1.5 Market Attractiveness Analysis, By Procedure
5.1.6 Market Share Analysis, By Procedure
5.2 Device
5.2.1 Introduction
5.2.2 Surgical Devices
5.2.2.1 Clamps
5.2.2.2 Trocars
5.2.2.3 Forceps
5.2.2.4 Retractors
5.2.2.5 Staplers
5.2.2.6 Cutters
5.2.2.7 Scissors
5.2.2.8 Elevators
5.2.2.9 RIB Sheers
5.2.3 Monitoring Devices
5.2.3.1 Cameras & Video Support
5.2.4 Visualizing Devices
5.2.4.1 Endoscopic Trocars with optical views
5.2.4.2 Endo surgical Equipment
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Procedure
6.1.3.3 By Device
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Procedure
6.1.4.3 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Procedure
6.1.5.3 By Device
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Ethicon US LLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Intuitive Surgical Inc.
8.3 Olympus Corporation
8.4 Accuray Inc.
8.5 AngioDynamics Inc.
8.6 Teleflex Inc.
8.7 KARL STORZ GmbH
8.8 Ackermann Instrumente GmbH
8.9 Scanlan International Inc.
8.10 Trokamed GmbH.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
